European Division Of Genscript News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from European division of genscript. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In European Division Of Genscript Today - Breaking & Trending Today

GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing An

Exclusive agreement for region brings GenScript s innovative cPass™ kit to Spain, Portugal and Andorra
LEIDEN, Netherlands & BILBAO, Spain (BUSINESS WIRE) GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation ( GenScript , Stock Code: 1548.HK), a world-leading biotechnology company, and IES Diagnostics, the Life Science division of IES Medical, a company based in Spain, announced they have signed an agreement for the exclusive distribution of the GenScript cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit in Spain, Portugal, and Andorra.
The test measures the presence of neutralizing antibodies (NAbs) in patients recovering from COVID-19 or receiving a vaccine. It is the only U.S. FDA Emergency Use Authorized (EUA) serology test for neutralizing antibodies from recent and prior SARS-CoV-2 infections. The kit is also CE marked (Europe) and has received HSA provisional approval (Singapore), ANVISA in Brazil, ANMAT in Argentina and has re ....

Hong Kong , Ministry Of Health , United Arab Emirates , Comunidad Autonoma De Cataluna , Maria Jos , Hubert Thomassen , Aaron Qian , Genscript Biotech Corporation , European Division Of Genscript , Genscript Biotech Corporation Stock Code , Genscript Biotech , Stock Code , Life Science , Antibody Detection Kit , Use Authorized , European Division , Script Biotech Corporation , Mainland China , Emergency Medicine , Script Biotech , ஹாங் காங் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , ஒன்றுபட்டது அரபு அமீரகங்கள் , காமுனிடட தன்னாட்சி டி கடலுள் , மரியா ஜோஸ் , ஸ்டாக் குறியீடு ,

GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit

Press release content from Business Wire. The AP news staff was not involved in its creation.
GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit
April 14, 2021 GMT
LEIDEN, Netherlands & BILBAO, Spain (BUSINESS WIRE) Apr 14, 2021
ADVERTISEMENT
The test measures the presence of neutralizing antibodies (NAbs) in patients recovering from COVID-19 or receiving a vaccine. It is the only U.S. FDA Emergency Use Authorized (EUA) serology test for neutralizing antibodies from recent and prior SARS-CoV-2 infections. The kit is also CE marked (Europe) and has received HSA provisional approval (Singapore), ANVISA in Brazil, ANMAT in Argentina and has recently received clearance from the Ministry of Health and Prevention (MOHAP) in the United Arab Emirates as a medical device. ....

Hong Kong , Ministry Of Health , United Arab Emirates , Comunidad Autonoma De Cataluna , Maria Jos , Hubert Thomassen , Aaron Qian , Genscript Biotech Corporation , European Division Of Genscript , Genscript Biotech Corporation Stock Code , Script Biotech , Stock Code , Life Science , Antibody Detection Kit , Use Authorized , European Division , Script Biotech Corporation , Mainland China , Emergency Medicine , Genscript Biotech , Business Wire , Public Health , Coronavirus Pandemic , Diagnosis And Treatment , Severe Acute Respiratory Syndrome , Health Care Industry ,